SynAct Pharma terminates agreement for liquidity providing

SynAct Pharma AB (publ) today announced that it has terminated its agreement with Sedemera Fondkommission to act as the company’s liquidity provider.

SynAct Pharma’s last trading day with a liquidity provider is November 13, 2020. 

For further information about SynAct Pharma AB, please contact:

Jeppe Øvlesen                                                                                Thomas Jonassen

CEO, SynAct Pharma AB                                                                CSO, SynAct Pharma AB

Phone: +45 28 44 75 67                                                                  Phone: +45 40 15 66 69
Mail: 
joo@synactpharma.com
                                                         Mail: tj@synactpharma.com